The ability of systemic AT1R inhibition to facilitate both extinction4,8, and to modify reconsolidation as shown here, suggest that AT1R blockade may be unique in its directional effects on fear memory and support a role for this receptor as a potential pharmacotherapeutic target for maladaptive fear disorders such as PTSD. The gene discussed is AGTR1; the disease is post-traumatic stress disorder.